Truven Blog

Welcome to our blog where you can be informed about the latest health and technology insights.

Filters

Showing results for


Clear all
Cell and gene therapy benefits planning: Using data to assess risk

Key takeaways:

By Katherine Shanahan | 6 min. read

From claims to clarity: Using MarketScan for stronger real-world evidence

In our webinar earlier this month, we discussed how MarketScan is more than a family...

By Liisa Palmer | 5 min. read

3 ideas from the Truven Summit shaping the future of health and benefits

Last week in Nashville, we hosted the Truven Summit. Health and benefits leaders...

By Truven | 4 min. read

Lessons learned from a Biodesix and MarketScan custom data linking project

As real‑world data (RWD) becomes a central pillar of evidence generation, the...

By Liisa Palmer | 3 min. read

Data & Analytics as a Service (DAaaS) in healthcare: Speed, scale, and sustainable insight

The story at a glance:

By Brandi Hodor | 7 min. read

Truven 2026 trends: What’s new with GLP-1s, gene therapy, and mental health

It’s a familiar theme at this point: healthcare costs are again expected to rise in...

By Merative | 6 min. read

How MarketScan data informs flu prevention strategies

Last week was National Influenza Vaccination Week (NIVW), and it is an important...

By Merative | 5 min. read

Niche vs. enterprise analytics: Choosing the right path for healthcare success

Healthcare organizations are awash in data—from clinical records to operational...

By Graham Newman, MPH | 4 min. read